Literature DB >> 22048012

Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany.

Sascha Abbas1, Peter Ihle, Ingrid Köster, Ingrid Schubert.   

Abstract

OBJECTIVE: The objectives were: (a) to determine the administrative prevalence and incidence of endometriosis and (b) to assess the risk of endometriosis associated with endometriosis-related symptoms. STUDY
DESIGN: The study is based on inpatient and outpatient data from a statutory health insurance fund in Germany. For prevalence and incidence definition 62,323 women aged 15-54 continuously insured in 2007 were identified. The prevalence and incidence of endometriosis in 2007 were calculated standardized to the age distribution in Germany. In a further prospective cohort study based within the health insurance sample 2095 patients with endometriosis-related symptoms and 8380 age-matched asymptomatic controls were identified. Endometriosis follow-up was from 2004 to 2008. Cox proportional hazard regression was used to examine the risk of endometriosis associated with endometriosis-related symptoms, such as pelvic pain, dysmenorrhoea, dyspareunia, menorrhagia, post-coital bleeding, inter-menstrual pain and ovarian cysts. Relative risks (RR) and 95% confidence intervals (CI) were calculated.
RESULTS: Standardized prevalence and incidence rates were 8.1 and 3.5 per 1000 women, respectively. The highest prevalence was observed in women aged 35-44 with 12.8 per 1000 women. Median follow-up was 4.5 years. Risk of endometriosis associated with endometriosis-related symptomatology was RR (95% CI)=4.95 (3.67-6.68); 4.5% of all symptomatic women were diagnosed with endometriosis in a median follow-up of 4.5 years. The highest risk was observed in women aged 35-44 [RR (95% CI)=6.29 (4.00-9.90)] with 7.6% of all symptomatic women receiving a diagnosis of endometriosis during the follow-up.
CONCLUSION: Prevalence estimates based on population-based administrative data were lower than described in the literature. Risk of endometriosis was increased in women with endometriosis-related symptoms. However, those symptoms were of limited predictive value for endometriosis as only a small proportion of symptomatic patients were diagnosed with endometriosis in the follow-up.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22048012     DOI: 10.1016/j.ejogrb.2011.09.041

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  33 in total

1.  Effect of simvastatin on baboon endometriosis.

Authors:  Hugh S Taylor; Myles Alderman Iii; Thomas M D'Hooghe; Asgerally T Fazleabas; Antoni J Duleba
Journal:  Biol Reprod       Date:  2017-07-01       Impact factor: 4.285

Review 2.  Systematic radiological approach to utero-ovarian pathologies.

Authors:  Olivera Nikolic; Marijana Basta Nikolic; Aleksandar Spasic; Mila Milagros Otero-Garcia; Sanja Stojanovic
Journal:  Br J Radiol       Date:  2019-06-06       Impact factor: 3.039

3.  Endometriosis-associated pain syndrome: a nurse-led approach.

Authors:  Julia Cambitzi; Maya Nagaratnam
Journal:  Br J Pain       Date:  2013-02

4.  Pointers to earlier diagnosis of endometriosis: a nested case-control study using primary care electronic health records.

Authors:  Christopher Burton; Lisa Iversen; Sohinee Bhattacharya; Dolapo Ayansina; Lucky Saraswat; Derek Sleeman
Journal:  Br J Gen Pract       Date:  2017-11-06       Impact factor: 5.386

5.  Supporting and Inhibiting Factors When Coping with Endometriosis From the Patients' Perspective.

Authors:  S Kundu; J Wildgrube; C Schippert; P Hillemanns; I Brandes
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-05       Impact factor: 2.915

6.  Prevalence of endometriosis among adolescent school girls with severe dysmenorrhea: A cross sectional prospective study.

Authors:  Ahmed Ragab; Maher Shams; Ahmed Badawy; Mohamed Alkhatim Alsammani
Journal:  Int J Health Sci (Qassim)       Date:  2015-07

7.  Female Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine Disrupting Chemicals in the European Union.

Authors:  Patricia A Hunt; Sheela Sathyanarayana; Paul A Fowler; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2016-03-22       Impact factor: 5.958

8.  An International Survey of Commonly Used Interventions for Management of Pelvic Pain.

Authors:  Meryl Alappattu; Sandra Hilton; Mark Bishop
Journal:  J Womens Health Phys Therap       Date:  2019 Apr-Jun

9.  Localization of claudin-2 and claudin-3 in eutopic and ectopic endometrium is highly similar.

Authors:  Alena Hoerscher; Fabian Horné; Raimund Dietze; Eniko Berkes; Frank Oehmke; Hans-Rudolf Tinneberg; Ivo Meinhold-Heerlein; Lutz Konrad
Journal:  Arch Gynecol Obstet       Date:  2020-03-05       Impact factor: 2.344

10.  Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older population.

Authors:  Matthias Hunger; Larissa Schwarzkopf; Margit Heier; Annette Peters; Rolf Holle
Journal:  BMC Health Serv Res       Date:  2013-01-03       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.